Related Experiment Videos
[Chemobrain]
Gyongyver Szentmartoni1, Zoltan Makkos, Magdolna Dank
1Semmelweis Egyetem Onkológiai Központ, Budapest, Hungary. titkarsag.dank@med.semmelweis-univ.hu.
Summary
Chemobrain, or chemotherapy-induced cognitive dysfunction, affects cancer survivors with lasting symptoms like memory loss. Understanding its mechanisms is crucial for developing effective treatments and improving quality of life.
Area of Science:
- Oncology
- Neuroscience
- Psychology
Background:
- Growing number of cancer survivors experience persistent cognitive dysfunction post-chemotherapy, termed chemobrain or chemofog.
- Chemobrain symptoms include memory impairment, attention deficits, and executive function disturbances, impacting quality of life.
- Current diagnostic methods (imaging, neuropsychological tests) lack consistency.
Purpose of the Study:
- To explore the multifaceted nature of chemotherapy-induced cognitive dysfunction (chemobrain).
- To identify potential contributing factors and understand the underlying pathomechanisms of chemobrain.
- To highlight the need for effective treatment strategies.
Main Methods:
- Review of structural and functional imaging studies (MRI, fMRI, PET).
- Analysis of neuropsychological testing data.
- Exploration of potential contributing factors such as nutrition, age, anemia, inflammation, stress, and depression.
Main Results:
- Chemobrain symptoms are prevalent and can be long-lasting, significantly affecting survivors' functionality.
- The specific pathomechanism of chemobrain remains unknown.
- Several factors including inflammation, stress, and depression are suspected to influence cognitive symptoms.
Conclusions:
- Understanding chemobrain pathomechanisms is vital for improving cancer survivor care.
- Further research into pharmacotherapies is ongoing.
- Insights into chemobrain may also illuminate cognitive dysfunction in depression.